Centerpoint Advisors, LLC
- SEC CIK
- 0001733788
- Latest filing
- Aug 5, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by Centerpoint Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −450−100.0% | Sold out | Holders |
| Q1 2026 | 450 | $89.0K | <0.1% | 00.0% | UnchangedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 900 | $83.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 900 | $69.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 900 | $63.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 900 | $66.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 900 | $59.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 900 | $70.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 900 | $70.0K | <0.1% | +780+650.0% | Added | Holders |
| Q1 2024 | 120 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 120 | $8.00K | <0.1% | −170−58.6% | Reduced | Holders |
| Q3 2023 | 290 | $20.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 290 | $21.0K | <0.1% | −335−53.6% | Reduced | Holders |
| Q1 2023 | 625 | $43.0K | <0.1% | +625 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −10−100.0% | Sold out | Holders |
| Q2 2022 | 10 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10 | $1.00K | <0.1% | +1+11.1% | Added | Holders |
| Q4 2021 | 9 | $1.00K | <0.1% | +9 | New | Holders |